GlassScriptPhysician profile
Alexander Jose Rodriguez
NPI 1174581821
$6,540.72
in general payments reported to CMS, 2019-2025
36 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $172 · 2021: $859 · 2022: $1,381 · 2023: $1,022 · 2024: $1,429 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,055.78 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $1,027.97 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $839.62 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $432.89 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $389.54 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $316.21 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $283.99 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $254.87 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $247.15 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $241.71 | 2019-2025 | Rexulti |
| Lundbeck LLC | $145.97 | 2023-2024 | Rexulti |
| Dexcom, INC. | $145.40 | 2021-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $140.16 | 2024 | Interstim |
| Urovant Sciences INC | $125.00 | 2022 | |
| Nestle Healthcare Nutrition INC. | $125.00 | 2021 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.